Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

TechCrunch - Sep 23, 2026

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Read full article

MORE NEWS

Science Thread

Science Thread delivers quality and fascinating science and technology content that matters on a daily basis and makes it go viral.

Sign Up